SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is facing extreme volatility and intense community backlash after a massive, rapid price rally was followed by a sharp collapse, leading to widespread accusations of an insider-led rug pull. While some traders are actively seeking short-term gains through dead cat bounces and technical setups, many community members are warning of a scam due to the highly concentrated token supply and ongoing investigations into potential market manipulation.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is capturing community attention as the project emphasizes long-term culture building, organic growth, and its alignment with cannabis advocacy ahead of 4/20. Participants are actively debating the token's potential for real-world integration in the cannabis space while closely monitoring community-led initiatives and social engagement.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging as a legacy project with deep roots in early internet culture, drawing significant attention for its historical status as the original crypto satire from 2011. The community is heavily focused on its long-standing lore, verifiable origins, and recent on-chain presence, with many investors viewing its unique narrative as a differentiator in the crowded memecoin market.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors weigh a critical BlueBird 7 satellite launch against a structured share sale by major stakeholder Rakuten. While community sentiment is heavily focused on the potential for a short squeeze and long-term constellation deployment, discussions are currently dominated by debates over launch cadence, the impact of the equity offering, and the company's ability to scale manufacturing to meet future targets.

Asteroid Shiba is inspired by a real-life event where a Shiba Inu plush toy named "Asteroid" served as a zero-gravity indicator during the Polaris Dawn mission. This connection to space travel gives it a narrative that's both whimsical and grounded in a tangible event, differentiating it from other meme coins which might rely solely on internet culture or celebrity endorsements.  The coin's mascot, the zero-gravity Shiba Inu, was designed by a young cancer survivor, Liv Perrotto, adding a layer of emotional connection and human interest story that's rare in the crypto space. This backstory not only provides a unique selling point but also a community rallying point.

Asteroid Shiba

Asteroid Shiba is generating significant buzz as a high-volatility memecoin following a rapid price surge, sparking intense debate among community members over whether it represents a sustainable growth opportunity or a speculative pump-and-dump cycle. While many traders are celebrating aggressive gains and comparing it to other viral tokens, others remain cautious, questioning the legitimacy of its rapid movement and advising others to lock in profits.

About Bancor? Bancor is an ecosystem of decentralized, open-source protocols that promote on-chain trading and liquidity.   Its main protocol, Carbon, is a decentralized trading protocol allowing users to perform automated trading strategies using custom on-chain limit orders and range orders, with the option of combining orders together to create automated buy low, sell high strategies.   Fast Lane, a separate open-source arbitrage protocol, allows any user to perform arbitrage between Bancor ecosystem protocols and external on-chain exchanges and redirect arbitrage profits back to the Bancor ecosystem.  All Bancor ecosystem protocols are governed by the BancorDAO via staked BNT.  What makes Bancor Unique? Bancor’s flagship protocol, Carbon, allows users to perform automated trading strategies on-chain with far greater control and efficiency compared to existing decentralized exchanges (DEXs).  Existing on-chain liquidity solutions suffer from key drawbacks, namely that: 1) executed orders can be reversed when prices move, and 2) a single liquidity position must execute both buys and sells using the same pricing curve. As a result, on-chain liquidity is costly and complex to automate and update, while exposing traders to MEV sandwich attacks.  Carbon introduces a new form of on-chain liquidity called Asymmetric Liquidity, which allows users to create individual liquidity positions with two distinct pricing curves: one for buying and one for selling. This gives users the ability to set buy and sell orders that execute in specific price ranges, with the option of combining orders together to create automated buy low, sell high strategies. By design, Carbon orders are irreversible on execution, easily adjustable directly on-chain, and completely resistant to MEV sandwich attacks. These capabilities give users an unprecedented level of control and automation to perform novel trading strategies on-chain.  For example, a user who believes ETH will trade in the near future between $1500-2000 could set a Carbon strategy that automatically buys ETH between $1500-1600 and sells the ETH from $1900-2000. As market prices move into selected ranges, orders are automatically executed by traders who interact with Carbon directly, or via popular DEX aggregators. All with no reliance on external oracles or keepers. Strategy updates can be made in a highly gas efficient manner, without needing to withdraw and re-add liquidity, via parameters in a strategy’s smart contract.  Carbon also improves on the trading model in centralized exchanges by allowing users to create multi-order strategies that utilize a single source of rotating liquidity to fill trades, eliminating the need to create multiple limit orders and pre-fund each order as it is created. By fusing the feature-rich trading functionality of centralized exchanges with the access and transparency of automated market-makers, Carbon unlocks the future of decentralized on-chain trading.  History of Bancor Bancor invented the first blockchain-based automated market maker (AMM) in 2017. The protocol’s first version was launched in June 2017, with subsequent protocol versions iterating on the original AMM model.  In 2020, the BancorDAO was launched to oversee and govern development of Bancor ecosystem protocols. The BancorDAO has since voted on over 450 governance proposals, and has had at the time writing over 9,700 governance token holders, and over 1,100 voters.  What’s Next for Bancor Per the BancorDAO, the Bancor community is focused on development of its flagship protocols, Carbon and Fast Lane. The beta version of Fast Lane is currently live on Ethereum mainnet, and will continue evolving, while the beta version of Carbon is expected to go live on Ethereum mainnet in the second quarter of 2023, pending voting by the BancorDAO. From there, deployment of both Carbon and Fast Lane on other Layer-1 and Layer-2 blockchains will be explored.   The Bancor community will continue executing on its mission to build innovative solutions that expand the design space for on-chain trading and liquidity and open the doors to a wide range of future DeFi applications and products.  What Can Bancor (BNT) Be Used For The Bancor Network Token (BNT) can currently be staked for vBNT to vote in BancorDAO governance, with additional BNT utility controlled by the BancorDAO.  Relevant Sources:  Bancor Github Carbon Website Introducing Carbon Blog Post Fast Lane Carbon Whitepaper Carbon Litepaper

Bancor

Bancor is trending due to a lawsuit filed against Uniswap over alleged patent infringement of its automated market maker (AMM) technology, sparking debate within the crypto community about intellectual property in DeFi; at the same time, Bancor is highlighted for its Arb Fast Lane protocol across multiple chains, and integration with Carbon DeFi, driving discussions around liquidity optimization and trading efficiency.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is experiencing significant market interest driven by institutional developments, including its inclusion in upcoming CME futures and active adoption across various DeFi and gaming protocols. Community sentiment is notably polarized, with many investors aggressively accumulating during dips and citing long-term potential, while others express caution regarding price volatility and project comparisons.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

Investors are actively rallying behind RETIRE as a community-driven alternative to traditional retirement plans, frequently discussing its potential for life-changing gains and long-term accumulation. The conversation centers on the project's ability to remain resilient during market volatility, with participants framing it as a movement against the established financial system.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as investors react to a recent corporate rebranding and executive shifts while monitoring clinical progress for its MDD and GAD treatment pipeline. Community sentiment is polarized, with some traders optimistic about the potential for regulatory tailwinds and upcoming trial data, while others remain skeptical due to the company's history of dilution and previous share price performance.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility as the community debates whether the asset is staging a breakout or entering a bear trap, with traders closely monitoring geopolitical tensions in the Middle East and speculative talk of peace deals. Sentiment remains deeply polarized, as investors weigh ongoing accumulation by institutional "whales" against bearish technical patterns and concerns regarding potential liquidations in the futures market.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IDEAYA Biosciences (NASDAQ:IDYA) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded IDEAYA Biosciences from a "sell" rating to a "hold" rating in a research note on Saturday...

IDEAYA Biosciences (NASDAQ:IDYA) Stock Price Down 3.5%  - Should You Sell?

IDEAYA Biosciences (NASDAQ:IDYA) Trading Down 3.5% - What's Next...

IDEAYA Biosciences (NASDAQ:IDYA) Given New $35.00 Price Target at The Goldman Sachs Group

The Goldman Sachs Group increased their price target on shares of IDEAYA Biosciences from $31.00 to $35.00 and gave the company a "neutral" rating in a report on Tuesday...

IDEAYA Biosciences (NASDAQ:IDYA) Given New $48.00 Price Target at Wells Fargo & Company

Wells Fargo & Company upped their price objective on shares of IDEAYA Biosciences from $44.00 to $48.00 and gave the stock an "overweight" rating in a research report on Tuesday...

Wedbush Forecasts Strong Price Appreciation for IDEAYA Biosciences (NASDAQ:IDYA) Stock

Wedbush upped their price target on shares of IDEAYA Biosciences from $52.00 to $58.00 and gave the company an "outperform" rating in a research report on Tuesday...

IDEAYA Biosciences (NASDAQ:IDYA) Stock Price Expected to Rise, Guggenheim Analyst Says

Guggenheim lifted their price target on IDEAYA Biosciences from $50.00 to $54.00 and gave the stock a "buy" rating in a research report on Tuesday...

Tudor Investment Corp ET AL Purchases New Position in IDEAYA Biosciences, Inc. $IDYA

Tudor Investment Corp ET AL purchased a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 37,595 shares of the company's stock, valued at approximately...

IDEAYA Biosciences Unveils OptimUM-02 Data: Darovasertib/Crizotinib Doubles PFS in Uveal Melanoma

IDEAYA Biosciences (NASDAQ:IDYA) shared top-line results from its randomized phase II/III OptimUM-02 study evaluating darovasertib in combination with crizotinib as a frontline treatment for HLA-A2 negative metastatic uveal melanoma. The webcast featured prepared remarks from Founder, President, and...

IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up - Time to Buy?

IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up - What's Next...

Futures Slide But Off Session Lows As Oil Spikes Above $100 Ahead Of Trump's 10am Hormuz Blockade

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

IDYA
Ideaya Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IDYA News

IDYAIdeaya Biosciences Inc